Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Zhuhai Institute of Medical Genetics, Zhuhai Women and Children's Hospital, Zhuhai, China.
Int J Lab Hematol. 2023 Aug;45(4):571-580. doi: 10.1111/ijlh.14059. Epub 2023 Mar 14.
Thalassemia is the most common monogenic disease in South and Southeast Asia. An accurate assessment of the relative frequency and composition of thalassemia mutations is important for the design of appropriate strategies to prevent the disease. In this study, we aimed to decode the molecular characterization of thalassemia mutations in Zhuhai region of southern China.
A total of 8048 individuals who were potential thalassemia carriers were enrolled. Gap-polymerase chain reaction (Gap-PCR) and reverse dot-blot (RDB) hybridization methods were employed to detect common deletional and non-deletional thalassemia mutations. Multiplex ligation dependent probe amplification (MLPA) and Sanger sequencing were used to analyze and verify rare and complex mutations.
We diagnosed 3433 individuals as thalassemia carriers or patients. Of these, 2395 (69.76%) individuals with α-thalassemia harbored 13 α-globin gene mutations. The three most common α-thalassemia mutations were -- (60.08%), -α (20.62%) and -α (9.25%). We diagnosed 903 (26.30%) individuals with β-thalassemia and identified 20 β-globin gene mutations, of which the three most frequent were CD41/42 (-TCTT) (38.10%), IVS-II-654 (C>T) (23.69%) and TATAbox-28 (A>G) (15.18%). In addition, we identified 15 rare thalassemia variants. We also summarized the association between the thalassemia genotype and hematological parameters, which demonstrated the broad phenotypic heterogeneity caused by globin gene mutations.
This is the first survey of thalassemia molecular epidemiology and hematological phenotype in Zhuhai region. It uncovered a high prevalence and complex molecular spectrum of thalassemia. These findings can be used as a basis for thalassemia diagnosis, counseling and prevention management.
地中海贫血是南亚和东南亚最常见的单基因疾病。准确评估地中海贫血突变的相对频率和组成对于制定预防该疾病的适当策略非常重要。在这项研究中,我们旨在解码中国南方珠海市地中海贫血突变的分子特征。
共纳入 8048 名潜在地中海贫血携带者。采用Gap-聚合酶链反应(Gap-PCR)和反向斑点杂交(RDB)杂交方法检测常见缺失和非缺失地中海贫血突变。采用多重连接依赖性探针扩增(MLPA)和 Sanger 测序分析和验证罕见和复杂突变。
我们诊断出 3433 名地中海贫血携带者或患者。其中,2395 名(69.76%)α-地中海贫血患者携带 13 种α-珠蛋白基因突变。三种最常见的α-地中海贫血突变是--(60.08%)、-α(20.62%)和-α(9.25%)。我们诊断出 903 名(26.30%)β-地中海贫血患者,共发现 20 种β-珠蛋白基因突变,其中最常见的三种是 CD41/42(-TCTT)(38.10%)、IVS-II-654(C>T)(23.69%)和 TATAbox-28(A>G)(15.18%)。此外,我们还鉴定了 15 种罕见的地中海贫血变异体。我们还总结了地中海贫血基因型与血液学参数之间的关联,这表明珠蛋白基因突变导致广泛的表型异质性。
这是珠海市地中海贫血分子流行病学和血液学表型的首次调查。它揭示了地中海贫血的高发率和复杂的分子谱。这些发现可作为地中海贫血诊断、咨询和预防管理的基础。